Sector Analysis · Healthcare & Life Sciences
A retailer’s outage costs a basket. A hospital’s outage diverts an ambulance. Healthcare is the one sector where the right answer to a low-confidence diagnosis is to refuse to act.
Ask a hospital CIO what happens when the EHR degrades and you will not hear about failover. You will hear about downtime boxes — printed forms, kept in a cupboard on every floor, for writing orders by hand. That is the recovery posture for a $4.9 trillion sector, and it exists because the alternative is worse.
US national health expenditure is approaching 17.6% of GDP. The estate that runs it is unusually heterogeneous: HL7v2 interfaces written decades ago sitting beside modern FHIR APIs, claims adjudication on mainframes, pharmacy benefit platforms answering in real time while a pharmacist waits at a counter. All of it load-bearing. None of it replaceable on a convenient schedule.
The characteristic healthcare failure is not a service falling over. It is a latency regression three hops deep in an eligibility check that surfaces as a provider-facing timeout with no obvious owner.
A prior-authorization request crosses an integration engine, a payer API, a benefits platform and back. When it slows, four teams are paged: the portal team because the symptom is theirs, the integration team because they are always paged, the payer-interface team because it might be upstream, and the platform team because it might be infrastructure. Three of those four spend the next hour proving it is not them.
Four teams paged for one fault is not an alerting problem. It is a correlation problem wearing an alerting problem’s clothes.
Two properties make this worse in healthcare than elsewhere. Interfaces are often organisational boundaries — the other side belongs to a payer, a clearinghouse, a lab network — so half the trace is outside your estate. And the systems are validated: changing application code to add instrumentation triggers a revalidation cost that means, in practice, it does not happen.
| Surface | How it presents |
|---|---|
| Clinical diversion | EHR degradation forces paper charting and ambulance diversion. The cost denominator includes patient outcomes, which is why operational-only figures always understate it. |
| Reportable events | HIPAA and HITECH make an availability incident simultaneously a potential disclosure event. The investigation has two audiences, one of them a regulator. |
| Pharmacy queue | Adjudication latency is felt locally and immediately — a person waiting at a counter — and is reputationally acute in a way that back-office downtime is not. |
| Seasonal concentration | Flu season, vaccination campaigns and January formulary changes create predictable annual stress the estate must absorb on a known date. |
| Validated-system paralysis | “Never touch it” and “keep it reliable” are in direct tension, and observability is often the only intervention that does not trigger revalidation. |
Healthcare is adopting AI quickly — ambient documentation, coding assistance, triage support, imaging pre-reads. Each addition places a probabilistic component in a path where the consequence of being wrong is clinical.
For reliability specifically, the risk is automated remediation. An agent that confidently restarts the wrong service during an EHR degradation has not saved an hour; it has extended the outage and contaminated the evidence. In a sector where the failure mode is a patient safety event, an automation that acts on a weakly-supported conclusion is worse than no automation at all.
There is also a data-governance dimension that healthcare feels more sharply than most. Traces and logs in a clinical estate contain PHI. The moment an investigating agent reads those logs, that content is in a model context window — possibly with a third party, possibly retained. The governance boundary moves without anyone having decided to move it.
The healthcare objective is not the fastest possible diagnosis. It is a diagnosis that can be defended afterwards — to a safety committee, to a regulator, to a board.
Both deployment models are available, and in healthcare the choice is usually decided by where PHI is allowed to live rather than by preference.
ThalamusTrace and Thalamus SRE run as managed instances, provisioned per region and tenancy model from one console. For payer analytics, revenue cycle, scheduling and other estates where the data can be de-identified or does not contain PHI, this is the fastest route — an instance in minutes rather than an infrastructure programme. Dedicated tenancy gives a separate database and a dedicated AWS account where a shared store is not acceptable to your privacy office.
Where PHI must not leave your boundary, the same platform deploys self-hosted inside your VPC or data centre. This is the common outcome for provider organisations and for anything touching the EHR. Customization typically covers three things: SLO definitions expressed in clinical terms rather than infrastructure ones (adjudication p95, order-entry availability, interface-engine throughput); guardrail policy mapped to your change-control tiers so clinical systems escalate by default; and redaction rules tuned to your PHI classification before telemetry reaches any agent.
| Engagement | What it produces |
|---|---|
| Clinical Path Mapping 3–4 weeks |
Which application paths have clinical consequence, what their real dependency graph looks like, and where the trace currently breaks at an organisational boundary. |
| PHI Telemetry Review 2–3 weeks |
Where PHI appears in traces and logs, which agents and vendors can read it, and a redaction design that preserves correlation while removing the identifiers. |
| Validated-Estate Instrumentation 6–8 weeks |
OTLP coverage across validated systems without application change, with the documentation your validation process requires produced alongside. |
| Guarded Rollout 8–12 weeks |
Self-hosted deployment, SLOs in clinical terms, guardrails mapped to your change tiers, and postmortems routed into your existing safety review. |
Healthcare estates are where automated remediation is least appropriate, and any vendor selling you self-healing clinical systems should be treated with suspicion — us included. The realistic value here is compressed diagnosis and defensible evidence, with a human making every decision that touches care.
If your organisation wants autonomous remediation across clinical paths, we are the wrong partner. We will configure the guardrails to prevent exactly that.
Four. Teams typically paged for a single upstream fault in a multi-hop eligibility or adjudication path. Three of them spend the first hour establishing that it is not them.
Correlation does not make the incident shorter by making engineers faster. It makes it shorter by not involving three-quarters of them in the first place.
Take your last five multi-service incidents. For each, count how many teams were paged and how many were causally involved.
That ratio is your correlation debt. In healthcare estates we have measured, it is rarely better than three to one — and it is paid in the most expensive engineering hours you have.